Teaching Hospital Universiti Putra Malaysia
Serdang, Malaysia
NCT Number: NCT03882294
The study will be aimed to investigate the effect of probiotic intervention and its associated factors on aflatoxin biomarkers among healthy subjects in Serdang and Kajang, Selangor
Looking for future studies?
Notify Me20 year–60 year
All sexes
Interventional
Not applicable
Serdang, Malaysia
The study will be a randomized, double-blind, placebo-controlled, parallel intervention that conducted for 12 weeks and followed-up for 4 weeks among healthy adults under living condition in Serdang and Kajang, Selangor. 164 subjects will be recruited for the intervention study, where 82 subjects will be randomly allocated to the probiotic or placebo group. Probiotic and placebo drinks (80 ml) will be prepared in the form of bottle. Placebo drink will have similar taste, colour, physical appearance, and nutritional value as probiotic drink but contain no LcS. Morning urine samples (15 ml), weight status, and dietary intake will be collected every two weeks from week 0 to week 12 and follow up until week 16 at community centre. Whereas, fasting blood samples (5 ml) and physical activity will be collected every four weeks for 16 weeks at the community centre.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will be requested to consume the drinks (80 ml) twice a day - after lunch and dinner for 12 weeks.
Participants will be requested to consume the drinks (80 ml) twice a day - after lunch and dinner for 12 weeks.
Time frame: From week 0 to week 16
Analysis of serum AFB1-lysine adducts will be done using elisa kit through HPLC.
Time frame: From week 0 to week 16
Analysis of urinary AFM1 will be done using elisa kit.
Time frame: From week 0 to week 16
Changes in weight and height will be measured using weighing scale and body meter respectively. Weight and height will be combined to report BMI in kg/m^2
Time frame: From week 0 to week 16
The parameter will be measured using measuring tape.
Time frame: From week 0 to week 16
The parameter will be examined using questionnaire based on the Global Physical Activity Questionnaire.
Time frame: From week 0 to week 16
Dietary assessment will be recorded via food frequency questionnaire (FFQ). The conversion of food frequency to the amount of food intake is carried out using the following formula:
Amount of food (g/day) = frequency of intake (conversion factor) × serving size × total of serving × weight of food in one serving (Wessex Institute of Public Health, 1995).
Time frame: From week 0 to week 16
KAP will be examined using questionnaire in bilingual (English and Bahasa Malaysia). Knowledge towards aflatoxin is scored into two groups: know and do not know. Attitudes and practices are categorized using likert scale with 1=strongly disagree, 2=disagree, 3=agree and 4=strongly agree.
Universiti Putra Malaysia
Other
Effect of Probiotics and Its Associated Factors on Aflatoxin Biomarkers Among Healthy Subjects in Serdang and Kajang, Selangor: A Twelve-week Intervention
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02188953
Aflatoxicosis, Aflatoxin Poisoning
Makindu, Kenya
View Trial DetailsNCT05583370
Aflatoxin Poisoning, Chemically-Induced Disorders
Asyut, Egypt
View Trial DetailsNCT01677195
Aflatoxin Poisoning, Chemically-Induced Disorders
San Antonio, Texas, United States
View Trial DetailsNCT06112834
Bacterial Infections, Bacterial Infections and Mycoses
Richmond, California, United States
View Trial Details